The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Select Medical Holdings Corp

NYSE: SEM
Last

(U.S.) $14.48

Today's change+0.18 +1.26%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.
 

Select Medical Holdings Corp

NYSE: SEM
Last

(U.S.) $14.48

Today's change+0.18 +1.26%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

Select Medical Holdings Corp crosses above 20-day moving average

Select Medical Holdings Corp closed up Friday by (U.S.)$0.18 or 1.26% to (U.S.)$14.48 and crossing above its 20-day moving average. Over the last five days, shares have gained 3.80% and 24.72% year to date. Shares have outperformed the S&P 500 by 24.27% during the last year.

Key company metrics

  • Open(U.S.) $14.28
  • Previous close(U.S.) $14.30
  • High(U.S.) $14.60
  • Low(U.S.) $14.20
  • Bid / Ask(U.S.) $10.83 / (U.S.) $14.61
  • YTD % change+24.72%
  • Volume1,757,375
  • Average volume (10-day)848,220
  • Average volume (1-month)731,033
  • Average volume (3-month)679,211
  • 52-week range(U.S.) $10.15 to (U.S.) $16.17
  • Beta1.11
  • Trailing P/E15.62×
  • P/E 1 year forward15.71×
  • Forward PEG1.57×
  • Indicated annual dividend(U.S.) $0.40
  • Dividend yield2.76%
  • Trailing EPS(U.S.) $0.93
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.34%

Based on its net profit margin of 4.34%, Select Medical Holdings Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue758773763746
Total other revenue--------
Total revenue758773763746
Gross profit114130124119
Total cost of revenue644643639628
Total operating expense692691686678
Selling / general / administrative30302934
Research & development--------
Depreciation / amortization18171617
Interest expense (income), net operating--------
Unusual expense (income)--020
Other operating expenses, total--------
Operating income66827668
Interest income (expense), net non-operating-22-22-21-21
Gain (loss) on sale of assets--------
Other--------
Income before tax46625649
Income after tax28383431
Income tax, total18242217
Net income27353329
Total adjustments to net income-1-1-1-1
Net income before extra. items27353329
Minority interest-2-3-1-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items26343228
Inc. avail. to common incl. extra. items26343228
Diluted net income26343228
Dilution adjustment--00--
Diluted weighted average shares127128130137
Diluted EPS excluding extraordinary itemsvalue per share0.200.270.250.21
Dividends per sharevalue per share0.100.100.100.10
Diluted normalized EPSvalue per share0.200.270.260.21